Vista Pharmaceuticals has informed that meeting of the Board of Directors of the company will be held on Saturday, the 10th day of February, 2024, at 4:30 pm at the Registered office of the Company to consider and approve the following: Un-Audited financial results for the quarter ended 31.12.2023, Limited Review Report for quarter ended 31.12.2023 and Any other business with the permission of the Chair.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1648.60 |
| Dr. Reddys Lab | 1305.00 |
| Cipla | 1277.55 |
| Zydus Lifesciences | 948.60 |
| Lupin | 2337.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: